XXXX -associated @entity662 : one-year follow-up.

@entity1 @entity662 @entity2072 @entity158 @entity583 @entity204
OBJECTIVE: To determine the one-year mortality and incidence of @entity583 ( @entity583 ) post-hospital discharge or ED release for @entity1 with @entity2072 -associated @entity662 . METHODS: A prospective, observational study of an inception cohort of consecutive @entity1 who presented to one of four municipal hospital EDs with @entity2072 -associated @entity662 . @entity1 were followed for one year from the end of the enrollment period. Main outcome parameters were the one-year actuarial survival and the frequency of nonfatal @entity583 . RESULTS: Mortality data were available for all 203 @entity1 at a mean of 408 days. Additional clinical information was available for 185 @entity1 (91%). There were six deaths (one-year actuarial survival 98%; 95% CI, 95-100%); none from @entity583 . Nonfatal @entity583 occurred in two @entity1 (1%; 95% CI, 0-2%). Continued @entity2072 use was common (60%; 95% CI, 52-68%) and was associated with recurrent @entity662 (75% vs 31%, p < 0.0001). No @entity583 or @entity204 was reported for @entity1 who claimed to have ceased @entity2072 use. CONCLUSIONS: @entity1 who presented with @entity2072 -associated @entity662 commonly continued to use @entity2072 after discharge. Urgent evaluation of coronary anatomy or cardiac stress tests may not be necessary for @entity1 for whom @entity583 is ruled out and who do not have recurrent potentially @entity158 . The subsequent risk for @entity583 and @entity204 in this group appears to be low. Intervention strategies should emphasize cessation of @entity2072 use.
